Seminal plasma induces angiogenic chemokine expression in cervical cancer cells and regulates vascular function

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 10, 2012, Pages 1789-1795

  Sales, Kurt J ^a   Sutherland, Jason R ^a   Jabbour, Henry N ^b   Katz, Arieh A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cervical cancer; Cyclooxygenase; Inflammation; Prostaglandin; Seminal fluid; Signalling

Indexed keywords

CHEMOKINE; CXCL3 CHEMOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN SYNTHASE;

ARTICLE; CANCER CELL; CARDIOVASCULAR FUNCTION; CELL THERAPY; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEMINAL PLASMA; UMBILICAL VEIN ENDOTHELIAL CELL; UTERINE CERVIX CANCER;

ANGIOGENESIS INDUCING AGENTS; BLOOD VESSELS; CHEMOKINE CXCL1; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-8; MALE; MODELS, BIOLOGICAL; PHOSPHORYLATION; SEMEN; SIGNAL TRANSDUCTION; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84864776553     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.06.021     Document Type: Article

References (37)

1. Lewis J.D., Deren J.J., Lichtenstein G.R. Cancer risk in patients with inflammatory bowel disease. Gastroenterol. Clin. North Am. 1999, 28:459-477.
2. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
3. Burn J., Gerdes A.M., Macrae F., Mecklin J.P., Moeslein G., Olschwang S., Eccles D., Evans D.G., Maher E.R., Bertario L., Bisgaard M.L., Dunlop M.G., Ho J.W., Hodgson S.V., Lindblom A., Lubinski J., Morrison P.J., Murday V., Ramesar R., Side L., Scott R.J., Thomas H.J., Vasen H.F., Barker G., Crawford G., Elliott F., Movahedi M., Pylvanainen K., Wijnen J.T., Fodde R., Lynch H.T., Mathers J.C., Bishop D.T. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011, 2081-2087.
4. Sitas F., Madhoo J., Wessie J. Incidence of histologically diagnosed cancer in South Africa, 1993-1995 1998, National Cancer Registry of South Africa, South African Institute for Medical Research, Johannesburg.
5. Arbyn M., Castellsague X., de Sanjose S., Bruni L., Saraiya M., Bray F., Ferlay J. Worldwide burden of cervical cancer in 2008. Ann. Oncol. 2011, 22:2675-2686.
6. Zur Hausen H. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009, 384:260-265.
7. Subbaramaiah K., Dannenberg A.J. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange. Cancer Res. 2007, 67:3976-3985.
8. Oh J.M., Kim S.H., Lee Y.I., Seo M., Kim S.Y., Song Y.S., Kim W.H., Juhnn Y.S. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells. Carcinogenesis 2009, 30:141-149.
9. Sales K.J., Jabbour H.N. Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. Prostaglandins Other Lipid Mediat. 2003, 71:97-117.
10. Sales K.J., Katz A.A., Howard B., Soeters R.P., Millar R.P., Jabbour H.N. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res. 2002, 62:424-432.
11. Sutherland J.R., Sales K.J., Jabbour H.N., Katz A.A. Seminal plasma enhances cervical adenocarcinoma cell proliferation and tumour growth in vivo. PLoS One 2012, 7:e33848.
12. Keightley M.C., Brown P., Jabbour H.N., Sales K.J. F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2. BMC Cell Biol. 2010, 11:8.
13. Maybin J.A., Hirani N., Jabbour H.N., Critchley H.O. Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair. Am. J. Pathol. 2011, 178:1245-1256.
14. Wang D., Wang H., Brown J., Daikoku T., Ning W., Shi Q., Richmond A., Strieter R., Dey S.K., DuBois R.N. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J. Exp. Med. 2006, 203:941-951.
15. Sales K.J., Maldonado-Perez D., Grant V., Catalano R.D., Wilson M.R., Brown P., Williams A.R., Anderson R.A., Thompson E.A., Jabbour H.N. Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway. Biochim. Biophys. Acta 2009, 1793:1917-1928.
16. Wallace A.E., Sales K.J., Catalano R.D., Anderson R.A., Williams A.R., Wilson M.R., Schwarze J., Wang H., Rossi A.G., Jabbour H.N. Prostaglandin F2alpha-F-prostanoid receptor signalling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma. Cancer Res. 2009, 69:5726-5733.
17. Muller M., Sales K.J., Katz A.A., Jabbour H.N. Seminal plasma promotes the expression of tumorigenic and angiogenic genes in cervical adenocarcinoma cells via the E-series prostanoid 4 receptor. Endocrinology 2006, 147:3356-3365.
18. Politch J.A., Tucker L., Bowman F.P., Anderson D.J. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum. Reprod. 2007, 22:2928-2935.
19. Perwez Hussain S., Harris C.C. Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 2007, 121:2373-2380.
20. Arici A., Seli E., Senturk L.M., Gutierrez L.S., Oral E., Taylor H.S. Interleukin-8 in the human endometrium. J. Clin. Endocrinol. Metab. 1998, 83:1783-1787.
21. Arici A., Seli E., Zeyneloglu H.B., Senturk L.M., Oral E., Olive D.L. Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. J. Clin. Endocrinol. Metab. 1998, 83:1201-1205.
22. Kayisli U.A., Mahutte N.G., Arici A. Uterine chemokines in reproductive physiology and pathology. Am. J. Reprod. Immunol. 2002, 47:213-221.
23. Ulukus M., Ulukus E.C., Seval Y., Zheng W., Arici A. Expression of interleukin-8 receptors in endometriosis. Hum. Reprod. 2005, 20:794-801.
24. Richmond A., Fan G.H., Dhawan P., Yang J. How do chemokine/chemokine receptor activations affect tumorigenesis?. Novartis Found. Symp. 2004, 256:74-89. (discussion 89-91, 106-111, 266-109).
25. Sharkey D.J., Macpherson A.M., Tremellen K.P., Robertson S.A. Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol. Hum. Reprod. 2007, 13:491-501.
26. Sharkey D.J., Tremellen K.P., Jasper M.J., Gemzell-Danielsson Robertson S.A. Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J. Immunol. 2012, 188(5):2445-2454.
27. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
28. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889-896.
29. Kelly R.W. Immunosuppressive mechanisms in semen: implications for contraception. Hum. Reprod. 1995, 10:1686-1693.
30. Robertson S.A. Seminal plasma and male factor signalling in the female reproductive tract. Cell Tissue Res. 2005, 322:43-52.
31. Hirata Y., Uchihashi M., Hazama M., Fujita T. Epidermal growth factor in human seminal plasma. Horm. Metab. Res. 1987, 19:35-37.
32. Battersby S., Sales K.J., Williams A.R., Anderson R.A., Gardner S., Jabbour H.N. Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway. Hum. Reprod. 2007, 22:36-44.
33. Jabbour H.N., Sales K.J., Boddy S.C., Anderson R.A., Williams A.R. A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signalling pathway. Endocrinology 2005, 146:4657-4664.
34. Fujino H., Regan J.W. Prostaglandin F(2alpha) stimulation of cyclooxygenase-2 promoter activity by the FP(B) prostanoid receptor. Eur. J. Pharmacol. 2003, 465:39-41.
35. Ausprunk D.H., Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 1977, 14:53-65.
36. Folkman J., Haudenschild C. Angiogenesis in vitro. Nature 1980, 288:551-556.
37. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.